Genetics of Behçet's disease

LT Morton, D Situnayake… - Current opinion in …, 2016 - journals.lww.com
Genetic and epigenetic changes affecting cells and molecules involved in Behçet's disease
offer new pathways for research, including cytoskeletal protein function, that will provide new …

Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis.

K Raza, M Breese, P Nightingale, K Kumar… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: To study the prognostic value of antibodies to cyclic citrullinated peptide (anti-
CCP) and rheumatoid factor (RF), alone and in combination, in patients with very early …

Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years

CS Yee, L Su, V Toescu, R Hickman… - …, 2015 - academic.oup.com
Objective. The aim of this study was to describe the outcomes and predictors for
development of damage in a large inception cohort of SLE patients. Methods. This was a …

[PDF][PDF] A multicenter, randomized, placebo‐controlled trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis

GD Kitas, P Nightingale, J Armitage… - Arthritis & …, 2019 - Wiley Online Library
Objective Rheumatoid arthritis (RA) is associated with increased cardiovascular event (CVE)
risk. The impact of statins in RA is not established. We assessed whether atorvastatin is …

The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE

B Griffiths, P Emery, V Ryan, D Isenberg, M Akil… - …, 2010 - academic.oup.com
Objective. To determine whether low-dose ciclosporin was a more effective corticosteroid-
sparing agent than AZA in patients with SLE. Methods. Patients with SLE requiring a change …

Epidemiology, morbidity and mortality in Behçet's disease: a cohort study using The Health Improvement Network (THIN)

T Thomas, JS Chandan, A Subramanian… - …, 2020 - academic.oup.com
Abstract Objectives The epidemiology of Behçet's disease (BD) has not been well
characterized in the UK. Evidence on the risk of cardiovascular disease, thromboembolic …

Successful treatment of calcinosis with infliximab in a patient with systemic sclerosis/myositis overlap syndrome

S Tosounidou, H MacDonald, D Situnayake - Rheumatology, 2014 - academic.oup.com
SIR, Calcinosis is a debilitating manifestation of many connective tissue diseases,
particularly JDM and SSc. Little is known about the pathogenesis of this condition, and its …

[HTML][HTML] Birmingham Behçet's service: classification of disease and application of the 2014 International Criteria for Behçet's Disease (ICBD) to a UK cohort

T Blake, L Pickup, D Carruthers, EM Damato… - BMC Musculoskeletal …, 2017 - Springer
Background This study reports on the analysis of the application and diagnostic
predictability of the revised 2014 ICBD criteria in an unselected cohort of UK patients, and …

Refractory multisystem sarcoidosis responding to infliximab therapy

AP Croft, D Situnayake, O Khair, G Giovanni… - Clinical …, 2012 - Springer
Chronic progressive multisystem granulomatous disease is seen in 10–30% of patients with
sarcoidosis and can result in end organ damage. Corticosteroids are the mainstay of …

Ten-year experience of pulsed intravenous cyclophosphamide and methylprednisolone protocol (PICM protocol) in severe ocular inflammatory disease

IJ Khan, RJ Barry, KN Amissah-Arthur… - British Journal of …, 2013 - bjo.bmj.com
Aims Severe ocular inflammation is a blinding ophthalmological emergency. This study
evaluates the efficacy and patient tolerance of a validated regime of pulsed intravenous …